Gemini PharmChem Mannheim GmbH activities are under full compliance with the worldwide valid GMP regulations. Gemini PharmChem develops a manufacturing process for New Chemical Entities (NCE) and/or supply the active pharmaceutical ingredients for all phases of a drug's life cycle, beginning with material for the first clinical studies up to the commercial supply.
Production assures the highest, consistent quality of their APIs to enable customers to run an effective process for the production of the finished drug forms.
Each year, approximately 300 kg of Active Pharmaceutical Ingredients, from 100 grams to 150 kilograms, leave their company and are delivered to customers in 21 countries on 5 continents. Gemini's team has significant experience in route development, optimization, scale-up pilot, and commercial scale chemistry for GMP and non-GMP productions.
We are looking forward to see your active participation in the network!
You can find here more information about Gemini PharmChem Mannheim GmbH.
Comments